Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-2.69%
1,068.24
-29.57
-2.69%
—1,097.811,087.761,087.761,067.42——
SIXC
Communications
SIXC
Communications
SIXC
-0.89%
606.59
-5.44
-0.89%
—612.03612.03612.03606.13——
SIXE
Energy
SIXE
Energy
SIXE
+2.19%
1,247.21
+26.78
+2.19%
—1,220.431,221.991,247.601,221.99——
SIXI
Industrials
SIXI
Industrials
SIXI
-1.82%
1,727.58
-31.94
-1.82%
—1,759.521,754.311,754.311,723.60——
SIXM
Financials
SIXM
Financials
SIXM
-0.32%
629.54
-2.00
-0.32%
—631.54631.27633.99628.63——
SIXR
Staples
SIXR
Staples
SIXR
-0.42%
853.60
-3.56
-0.42%
—857.16858.91861.71852.33——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-1.56%
212.04
-3.37
-1.56%
—215.41215.41215.41211.88——
SIXT
Technology
SIXT
Technology
SIXT
-1.78%
3,549.76
-64.39
-1.78%
—3,614.153,556.243,598.363,516.86——
SIXU
Utilities
SIXU
Utilities
SIXU
-2.40%
886.49
-21.81
-2.40%
—908.30906.55906.55885.88——
SIXV
Health care
SIXV
Health care
SIXV
-1.08%
1,464.34
-16.06
-1.08%
—1,480.401,479.551,484.431,462.52——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-1.84%
2,354.25
-44.12
-1.84%
—2,398.372,373.092,373.092,350.27——
4549:TYO
Eiken Chemical Co Ltd
Â¥2,844.00
-0.73%
(-21.00) 1D
May 15, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4549...
Open
Â¥2,852
High
Â¥2,872
Low
Â¥2,821
Mkt. cap
98.24B
Avg. vol.
185.23K
Volume
130.00K
Dividend
2.04%
Quarterly dividend
Â¥15
Ex dividend date
Sep 29, 2025
P/E ratio
25.37
52-wk high
Â¥3,500
52-wk low
Â¥1,972
EPS
Â¥112
Shares outstanding
36.88M
No. of employees
702
News stories
From sources across the web
Profile
Eiken Chemical is a Japanese company headquartered in Tokyo, established in 1939. The company's business is manufacturing and sales of clinical diagnostics and equipment. Eiken's major products include fecal immunochemical test reagents, immunological and serological reagents, microbiological reagents, urinalysis test strips, clinical chemistry reagents, molecular genetics, medical devices and industrial products. The company in 1998 developed the Loop-mediated isothermal amplification method, a nucleic acid amplification method, and an alternative to traditional PCR. Wikipedia
About Eiken Chemical Co Ltd
CEOMorifumi Wada
Employees702
FoundedFeb 20, 1939
Headquarters-
SectorMedical device
Websiteeiken.co.jp
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
10.20B
10.23B
10.95B
10.52B
Cost of goods sold
6.09B
5.96B
6.70B
6.97B
Cost of revenue
6.09B
5.96B
6.70B
6.97B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.30B
3.34B
3.20B
3.41B
Operating expense
3.30B
3.34B
3.20B
3.41B
Total operating expenses
9.40B
9.30B
9.90B
10.38B
Operating income
801.00M
928.00M
1.05B
141.00M
Other non operating income
34.00M
6.00M
-54.00M
19.00M
EBT including unusual items
814.00M
2.91B
1.00B
102.00M
EBT excluding unusual items
814.00M
915.00M
995.00M
-1.89B
Income tax expense
214.00M
535.00M
260.00M
116.00M
Effective tax rate
26.29%
18.36%
25.92%
113.73%
Other operating expenses
-
-
-
-
Net income
600.00M
2.38B
743.00M
-14.00M
Net profit margin
5.88%
23.25%
6.79%
-0.13%
Earnings per share
-
-
-
-
Interest and investment income
4.00M
8.00M
4.00M
5.00M
Interest expense
-4.00M
-5.00M
-5.00M
-15.00M
Net interest expenses
-
3.00M
-1.00M
-10.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.37B
1.50B
1.62B
775.00M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer